What's new

Recently, we participated in a study to review the ongoing impacts of nuclear tests conducted in the Montebello islands off the north coast of Western Australia.

In June 2018, ARPANSA issued a direction to its licence holder, the Australian Nuclear Science and Technology Organisation (ANSTO), to initiate an independent review of its approach to occupational radiation safety at its nuclear medicine facility operated by ANSTO Health, now known as Health Products.

The Australian Radiation Protection and Nuclear Safety (ARPANS) Regulations provide a framework for ensuring Commonwealth Government bodies that use or produce radiation conduct their work in a safe and responsible manner.

ARPANSA is pleased to host, in conjunction with the International Commission of Radiological Protection (ICRP) and the Australasian Radiation Protection Society (ARPS), the 5th International Symposium on the System of Radiological Protection on 17-21 November 2019 in Adelaide, South Australia.

The Annual Report of the CEO of ARPANSA 2018-19 was tabled in parliament on Tuesday 15 October 2019 and is now available on the new transparency portal.

Earlier this month ARPANSA and Cancer Council Victoria (CCV) met to formalise our partnership to promote sun safety and support skin cancer prevention.

In December 2018, the British Medical Journal Open published a scientific study led by ARPANSA investigating the relationship between brain cancer and mobile phone use.
Since the publication of the original study, the authors have conducted further analysis of additional age groups.

ARPANSA collates and publishes an annual report on radiation incidents in Australia. This report is produced with input from various radiation regulators around the country, based on incidents submitted to them and any subsequent investigations they carry out.